Loading Dose of Levetiracetam (Keppra)
For status epilepticus in adults, administer levetiracetam 40-60 mg/kg IV (maximum 4500 mg) as a loading dose, which can be given undiluted as an IV push over 5-15 minutes or diluted over 15 minutes.
Adult Dosing
Status Epilepticus (Benzodiazepine-Refractory)
- Loading dose: 40-60 mg/kg IV (maximum 2500-4500 mg) 1
- Administration: Can be given as undiluted IV push over 5-15 minutes or diluted in 100 mL compatible fluid over 15 minutes 2
- The 2019 Nature Reviews Clinical Oncology guidelines specifically recommend 40 mg/kg (maximum 2500 mg) IV bolus for both convulsive and non-convulsive status epilepticus in the CAR T-cell therapy population 1
Second-Line Agent (After Benzodiazepines)
- 30 mg/kg IV delivered at 5 mg/kg per minute is effective, with 73% seizure cessation rates 3
- The 2014 Annals of Emergency Medicine guideline supports levetiracetam as equally effective as fosphenytoin or valproate for benzodiazepine-refractory status epilepticus 3, 4
Standard Epilepsy Loading (Non-Emergency)
- 1500 mg IV over 15 minutes is commonly used 3
- FDA-approved dosing for switching from oral: equivalent to total daily oral dose 2
Pediatric Dosing
Status Epilepticus
- 40 mg/kg IV bolus (maximum 2500 mg) 1
- Followed by maintenance: 15-30 mg/kg IV every 12 hours depending on seizure control 1
Age-Specific Loading Doses (Non-Status)
- 1 month to <6 months: 14 mg/kg/day divided twice daily 2
- 6 months to <4 years: 20 mg/kg/day divided twice daily 2
- 4 years to <16 years: 20 mg/kg/day divided twice daily 2
- Safety data supports 50 mg/kg loading dose (maximum 2500 mg) over 15 minutes in children 5
Administration Methods
Undiluted IV Push (Preferred for Emergencies)
- Significantly faster administration: 12 minutes vs 38-44 minutes for diluted infusion 6
- Safe at doses up to 4500 mg given over 5-15 minutes 6, 7, 8
- No increased adverse events compared to diluted administration 6, 7, 9, 8
- Reduced ICU admissions in status epilepticus patients (adjusted OR 0.23) 6
- Can be administered via peripheral IV line 7
Diluted IV Infusion (Traditional Method)
- Dilute in 100 mL compatible diluent (0.9% NaCl, LR, D5W) 2
- Maximum concentration: 15 mg/mL 2
- Infuse over 15 minutes 2
- Disadvantage: Significant drug waste (57.6% of diluted bags not administered) 9
Safety Profile
Levetiracetam has an excellent safety profile with minimal adverse effects:
- No significant hemodynamic instability (hypotension <3.2%, bradycardia <2.3%) 4, 6
- No cardiac arrhythmias 4
- Minimal sedation (6-12%) 4
- No infusion site reactions with undiluted administration 7, 9
- Caution: Higher doses (>40 mg/kg) associated with increased intubation rates (45.8% vs 26-28%) 10
Clinical Considerations
Efficacy
- Seizure cessation rates: 44-73% within 60 minutes for benzodiazepine-refractory status epilepticus 3, 4
- Equivalent efficacy to fosphenytoin and valproate as second-line agents 4
- No difference in seizure termination between 20 mg/kg, 30 mg/kg, or 40-60 mg/kg doses 10
Renal Impairment
- Dose adjustment required in adults with CrCl <80 mL/min 2
- Normal renal function: 500-1500 mg every 12 hours
- Mild impairment (CrCl 50-80): 500-1000 mg every 12 hours
- Moderate impairment (CrCl 30-50): 250-750 mg every 12 hours
- Severe impairment (CrCl <30): 250-500 mg every 12 hours
- ESRD on dialysis: 500-1000 mg every 24 hours with 250-500 mg supplemental dose post-dialysis 2
Common Pitfalls
- Avoid underdosing: Doses <30 mg/kg may be less effective in status epilepticus 3
- Don't delay for dilution: Undiluted IV push is faster and equally safe 6, 7
- Monitor for behavioral changes: 13% of adults and 38% of pediatric patients experience behavioral symptoms with chronic use 2
- Avoid abrupt discontinuation: Taper to reduce risk of increased seizure frequency 2